The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
Open accessAbstract
OBJECTIVE: Genistein is a soy isoflavone that has antitumor activity both in vitro and in vivo. It has been shown that genistein inhibits many type of cancers including prostate cancer (PCa) by regulating several cell signaling pathways and microRNAs (miRNAs). Recent studies suggest that the long non-coding RNAs (lncRNAs) are also involved in many cellular processes. At present there are no reports about the relationship between gensitein, miRNAs and lncRNAs. In this study, we focused on miRNAs, lncRNA that are regulated by genistein and investigated their functional role in PCa. METHOD: Microarray (SurePrint G3 Human GE 8×60K) was used for expression profiling of genistein treated and control PCa cells (PC3 and DU145). Functional assay (cell proliferation, migration, invasion, apoptosis and cell cycle assays) were performed with the PCa cell lines, PC3 and DU145. Both in vitro and in vivo (nude mouse) models were used for growth assays. Luciferase reporter assays were used for binding of miR-34a to HOTAIR. RESULTS: LncRNA profiling showed that HOTAIR was highly regulated by genistein and its expression was higher in castration-resistant PCa cell lines than in normal prostate cells. Knockdown (siRNA) of HOTAIR decreased PCa cell proliferation, migration and invasion and induced apoptosis and cell cycle arrest. miR-34a was also up-regulated by genistein and may directly target HOTAIR in both PC3 and DU145 PCa cells. CONCLUSIONS: Our results indicated that genistein inhibited PCa cell growth through down-regulation of oncogenic HOTAIR that is also targeted by tumor suppressor miR-34a. These findings enhance understanding of how genistein regulates lncRNA HOTAIR and miR-34a in PCa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
GENCODE: The reference human genome annotation for The ENCODE Project
Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. (2012) · Genome Research · doi:10.1101/gr.135350.111 · Cited by 4,585
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“HOTAIR interacts with both PRC2 and lysine specific demethylase 1 (LSD1) complexes and couples histone H3 lysine 27 methylation and lysine 4 demethylation for epigenetic silencing of not only HOXD genes but also many other genes [28].”
BackgroundThe evolution of gene regulation by transcription factors and microRNAs
Chen, K., & Rajewsky, N. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1990 · Cited by 1,547
Genetic variation in microRNA networks: the implications for cancer research
Ryan, B. M., Robles, A. I., & Harris, C. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2867 · Cited by 1,257
Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1021 · Cited by 1,238
Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1914 · Cited by 1,029
Wang, J., Liu, X., Wu, H., Ni, P., Gu, Z., Qiao, Y., Chen, N., Sun, F., & Fan, Q. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq285 · Cited by 998
miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNA
Hansen, T. B., Wiklund, E. D., Bramsen, J. B., Villadsen, S. B., Statham, A. L., Clark, S. J., & Kjems, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.359 · Cited by 991
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S., & Safe, S. (2013) · Oncogene · doi:10.1038/onc.2012.193 · Cited by 782
Yang, Z., Zhou, L., Wu, L.-M., Lai, M.-C., Xie, H.-Y., Zhang, F., & Zheng, S.-S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1581-y · Cited by 708
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C. M., & Patel, T. (2011) · Oncogene · doi:10.1038/onc.2011.193 · Cited by 642
GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists
Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M., & Pascual-Montano, A. (2007) · Genome Biology · doi:10.1186/gb-2007-8-1-r3 · Cited by 592
lncRNAdb: a reference database for long noncoding RNAs
Amaral, P. P., Clark, M. B., Gascoigne, D. K., Dinger, M. E., & Mattick, J. S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1138 · Cited by 584
GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics
Tabas-Madrid, D., Nogales-Cadenas, R., & Pascual-Montano, A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks402 · Cited by 536
miR-146a Suppresses Invasion of Pancreatic Cancer Cells
Li, Y., VandenBoom, T. G., Wang, Z., Kong, D., Ali, S., Philip, P. A., & Sarkar, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2792 · Cited by 421
RhoGDI: multiple functions in the regulation of Rho family GTPase activities
Dovas, A., & Couchman, J. R. (2005) · Biochemical Journal · doi:10.1042/bj20050104 · Cited by 412
Large Intervening Non-Coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression
Geng, Y., Xie, S., Li, Q., Ma, J., & Wang, G. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900608 · Cited by 407
MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300
Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I., Srinivas, V., & Caro, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209702200 · Cited by 370
Wnt signaling pathways meet Rho GTPases
Schlessinger, K., Hall, A., & Tolwinski, N. (2009) · Genes & Development · doi:10.1101/gad.1760809 · Cited by 366
Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605570 · Cited by 325
Self-citationLi, Y., & Sarkar, F. H. (2002) · PubMed · Cited by 324
Sinner, D., Kordich, J. J., Spence, J. R., Opoka, R., Rankin, S., Lin, S.-C. J., Jonatan, D., Zorn, A. M., & Wells, J. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02179-06 · Cited by 321
Li, D., Feng, J., Wu, T., Wang, Y., Sun, Y., Ren, J., & Liu, M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.042 · Cited by 307
Soy Food Consumption and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Hwang, Y. W., Kim, S. Y., Jee, S. H., Kim, Y. N., & Nam, C. M. (2009) · Nutrition and Cancer · doi:10.1080/01635580902825639 · Cited by 234
Cui, Z., Ren, S., Lu, J., Wang, F., Xu, W., Sun, Y., Wei, M., Chen, J., Gao, X., Xu, C., et al. (2013) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.11.030 · Cited by 187
Zhang, W., Glöckner, S. C., Guo, M., Machida, E. O., Wang, D. H., Easwaran, H., Van Neste, L., Herman, J. G., Schuebel, K. E., Watkins, D. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6349 · Cited by 186
Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer
Chiyomaru, T., Yamamura, S., Fukuhara, S., Hidaka, H., Majid, S., Saini, S., Arora, S., Deng, G., Shahryari, V., Chang, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058929 · Cited by 176
Self-citationXu, B., Wang, N., Wang, X., Tong, N., Shao, N., Tao, J., Li, P., Niu, X., Feng, N., Zhang, L., et al. (2012) · The Prostate · doi:10.1002/pros.22466 · Cited by 167
Yamamura, S., Saini, S., Majid, S., Hirata, H., Ueno, K., Deng, G., & Dahiya, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029722 · Cited by 155
Self-citationThe functions of microRNAs in pluripotency and reprogramming
Leonardo, T. R., Schultheisz, H. L., Loring, J. F., & Laurent, L. C. (2012) · Nature Cell Biology · doi:10.1038/ncb2613 · Cited by 149
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
Jia, Y., Yang, Y., Liu, S., Herman, J. G., Lu, F., & Guo, M. (2010) · Epigenetics · doi:10.4161/epi.5.8.13104 · Cited by 139
Sun, Q., Cong, R., Yan, H.-L., Gu, H., Zeng, Y., Liu, N., Chen, J., & Wang, B. (2009) · Oncology Report · doi:10.3892/or_00000472 · Cited by 136
Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151
Chiyomaru, T., Yamamura, S., Zaman, M. S., Majid, S., Deng, G., Shahryari, V., Saini, S., Hirata, H., Ueno, K., Chang, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043812 · Cited by 113
Self-citationGenistein protects pancreatic β cells against cytokine-mediated toxicity
Kim, E., Kwon, K., Song, M., Seo, S.-W., Park, S., Ka, S., Lv, N., Kim, K., Ryu, D., So, H., et al. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.08.003 · Cited by 92
Association between lncrna PCGEM1 polymorphisms and prostate cancer risk
Xue, Y., Wang, M., Kang, M., Wang, Q., Wu, B., Chu, H., Zhong, D., Qin, C., Yin, C., Zhang, Z., et al. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2013.6 · Cited by 75
Vader, P., van der Meel, R., Symons, M. H., Fens, M. H. A. M., Pieters, E. H. E., Wilschut, K. J., Storm, G., Jarzabek, M. A., Gallagher, W. M., Schiffelers, R. M., et al. (2011) · Angiogenesis · doi:10.1007/s10456-011-9229-x · Cited by 57
Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer
de Souza, P. L., Russell, P. J., Kearsley, J. H., & Howes, L. G. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00314.x · Cited by 43
Yan, G., Yin, X., Xiao, C., Tan, Z.-L., Xu, S., & He, Q. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.09.008 · Cited by 29
Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.
Liss, M. A., Schlicht, M. J., Kahler, A., Fitzgerald, R. T., Thomassi, T., DeGueme, A. M., Hessner, M., & Datta, M. W. (2010) · PubMed · Cited by 25
Cited by
Analyzing MiRNA–LncRNA Interactions
Paraskevopoulou, M. D., & Hatzigeorgiou, A. G. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3378-5_21 · Cited by 895
Functional interactions among microRNAs and long noncoding RNAs
Yoon, J.-H., Abdelmohsen, K., & Gorospe, M. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.05.015 · Cited by 655
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
lncRNAs and microRNAs with a role in cancer development
Liz, J., & Esteller, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.015 · Cited by 512
Mir-34: A New Weapon Against Cancer?
Misso, G., Di Martino, M. T., De Rosa, G., Farooqi, A. A., Lombardi, A., Campani, V., Zarone, M. R., Gullà, A., Tagliaferri, P., Tassone, P., et al. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.47 · Cited by 498
Metadata
- Authors
- Chiyomaru, T., Yamamura, S., Fukuhara, S., Yoshino, H., Kinoshita, T., Majid, S., Saini, S., Chang, I., Tanaka, Y., Enokida, H., Seki, N., Nakagawa, M., & Dahiya, R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-01
- Volume
- 8
- Issue
- 8
- Pages
- e70372
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2056593219
- Cited by
- 266
- References
- 45
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.